Navigation Links
RESPONSE to the FDA and Public Health Experts Findings on Electronic Cigarettes
Date:7/23/2009

LOS ANGELES, July 23 /PRNewswire/ -- Yesterday, the FDA announced that after laboratory analysis of electronic cigarette samples they have discovered that Electronic Cigarettes contain carcinogens and toxic chemicals. However, this does not ring true for U.S. based manufacturer, SmokeStik, LTD. The FDA report analyzed e-cigarettes cartridges and listed several compounds of concern, such as, Diethylene Glycol, Tobacco specific nitrosamines, Anabasine, and Myosmine. Independent lab results have shown that none of these compounds are present in SmokeStik products.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090723/LA51264)

SmokeStik has released the following statement:

"As a company that is categorized in the 'e-cigarette' industry, SmokeStik is both aware and concerned about the FDA's findings released yesterday regarding electronic cigarettes. While we cannot speak specifically to the components of NJOY or Smoking Everywhere's cartridges, we do understand from public sources that these cartridges are imported from China. As many of our distributors are aware, as of last month, SmokeStik's cartridges are now made domestically. Moreover, all of the ingredients in SmokeStik's cartridges are certified by independent laboratories and most importantly; do NOT contain any of the carcinogens referenced in the Final Report on FDA Analyses.

SmokeStik has always presented its products as an 'alternative' for responsible, adult smokers, and not as a smoking cessation product. SmokeStik has NEVER sold flavored cartridges such as those referenced in the FDA's Report. As a company, we oppose this type of marketing and discourage teenagers from using our products."

If you would like to speak with SmokeStik, please contact Alexis Wallsh at Entertainment Fusion Group, alexis@efgpr.com or 310.432.0020.

About SmokeStik, LTD

SmokeStik, LTD is a U.S.-based manufacturer of the alternative smoking device, SmokeStik. SmokeStik effectively replicates the smoking experience while eliminating carcinogens, secondhand smoke, odor and litter. SmokeStik poses no health risks, thereby contributing to the reduction of the leading cause of preventable death in America - tobacco; SmokeStik is available in the U.S., the EU and South America. For more information, please visit www.SmokeStik.com.


'/>"/>
SOURCE SmokeStik, LTD
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cell division find prompts overhaul of immune response modeling
2. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
3. Camp High Harbour Response to Flu Outbreak Includes SpectraSan 24 Disinfectant
4. CIFOR Guidelines for Foodborne Disease Outbreak Response Published by National Food Safety Group
5. Emdeon To Collaborate With Rx Response in Critical Pharmacy Disaster Reporting
6. Accumetrics VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly-Approved Prasugrel (Effient(R))
7. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
8. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
9. Immune Response May Speed AIDS Progression in Women
10. Statement by Jim OHara, Director, Produce Safety Project, in Response to the White House Announcement on the Proposed FDA Rule on Produce Safety
11. Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: